Search Results - "BRUSS, J. B"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects by SLATTER, J. G, STALKER, D. J, STRYD, R. P, PENG, G. W, SHOBE, E. M, FEENSTRA, K. L, WELSHMAN, I. R, BRUSS, J. B, SAMS, J. P, JOHNSON, M. G, SANDERS, P. E, HAUER, M. J, FAGERNESS, P. E

    Published in Drug metabolism and disposition (01-08-2001)
    “…Linezolid (Zyvox), the first of a new class of antibiotics, the oxazolidinones, is approved for treatment of Gram-positive bacterial infections, including…”
    Get full text
    Journal Article
  2. 2

    Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections by Stevens, D L, Smith, L G, Bruss, J B, McConnell-Martin, M A, Duvall, S E, Todd, W M, Hafkin, B

    Published in Antimicrobial Agents and Chemotherapy (01-12-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Source Control Review in Clinical Trials of Anti-Infective Agents in Complicated Intra-Abdominal Infections by Solomkin, Joseph S., Ristagno, Ross L., Das, Anita F., Cone, John B., Wilson, Samuel E., Rotstein, Ori D., Murphy, Brian S., Severin, Kimberley S., Bruss, Jon B.

    Published in Clinical infectious diseases (15-06-2013)
    “…In clinical trials of complicated intra-abdominal infections, assessment of adequacy of the initial surgical approach to the management of the infection is of…”
    Get full text
    Journal Article
  4. 4

    Hematologic Effects of Linezolid: Summary of Clinical Experience by GERSON, Stanton L, KAPLAN, Sheldon L, BRUSS, Jon B, LE, Vu, ARELLANO, Felix M, HAFKIN, Barry, KUTER, David J

    Published in Antimicrobial Agents and Chemotherapy (01-08-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin by BRUSS, JON B, MALLEY, RICHARD, HALPERIN, SCOTT, DOBSON, SIMON, DHALLA, MOHSIN, MCIVER, JAMES, SIBER, GEORGE R

    Published in The Pediatric infectious disease journal (01-06-1999)
    “…BACKGROUND.Pertussis in infants is often severe, resulting in complications and prolonged hospitalization. Treatment is limited to supportive care. Antibiotics…”
    Get full text
    Journal Article
  6. 6

    Safety and tolerability of linezolid in children by SAIMAN, LISA, GOLDFARB, JOHANNA, KAPLAN, SHELDON A, WIBLE, KENNETH, EDGE-PADBURY, BARBARA, NABERHUIS-STEHOUWER, SHARON, BRUSS, JON B

    Published in The Pediatric infectious disease journal (01-09-2003)
    “…BACKGROUND.Linezolid, an oxazolidinone, is effective in the treatment of adults and children with community-acquired and nosocomial pneumonia and uncomplicated…”
    Get full text
    Journal Article
  7. 7

    Similarity of the oral microbiota of pre-school children with that of their caregivers in a population-based study by Tanner, A. C. R., Milgrom, P. M., Kent Jr, R., Mokeem, S. A., Page, R. C., Liao, S. I. A., Riedy, C. A., Bruss, J. B.

    Published in Oral microbiology and immunology (01-12-2002)
    “…This study evaluated the similarity between the oral microbiota of young children and that of their adult caregivers. Oral samples from children (174 dentate…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model by Bruss, J B, Siber, G R

    “…Pertussis in infants is often severe, resulting in prolonged hospitalization. Treatment is limited to supportive care. Antibiotics do not significantly alter…”
    Get full text
    Journal Article
  10. 10

    Quantitative Priming with Inactivated Pertussis Toxoid Vaccine in the Aerosol Challenge Model by BRUSS, Jon B, SIBER, George R

    Published in Infection and Immunity (01-08-2002)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11

    Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children by KAPLAN, SHELDON L, DEVILLE, JAIME G, YOGEV, RAM, MORFIN, MA RAYO, WU, ELBA, ADLER, STUART, EDGE-PADBURY, BARBARA, NABERHUIS-STEHOUWER, SHARON, BRUSS, JON B

    Published in The Pediatric infectious disease journal (01-08-2003)
    “…BACKGROUND.Pediatric infections caused by resistant Gram-positive infections are an increasing concern with limited treatment options. Linezolid, a new…”
    Get full text
    Journal Article
  12. 12

    Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates by DEVILLE, JAIME G, ADLER, STUART, AZIMI, PARVIN H, JANTAUSCH, BARBARA A, MORFIN, MARIA RAYO, BELTRAN, SANDRA, EDGE-PADBURY, BARBARA, NABERHUIS-STEHOUWER, SHARON, BRUSS, JON B

    Published in The Pediatric infectious disease journal (01-09-2003)
    “…BACKGROUND.Gram-positive infections caused by susceptible and resistant strains of Staphylococcus aureus, coagulase-negative staphylococci and enterococci are…”
    Get full text
    Journal Article
  13. 13

    Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant Gram-positive bacterial pathogens by JANTAUSCH, BARBARA A, DEVILLE, JAIME, ADLER, STUART, MORFIN, MARIA RAYO, LOPEZ, PIO, EDGE-PADBURY, BARBARA, NABERHUIS-STEHOUWER, SHARON, BRUSS, JON B

    Published in The Pediatric infectious disease journal (01-09-2003)
    “…BACKGROUND.Nosocomial infections, particularly hospital-acquired pneumonia (HAP) and bacteremia, are an increasing concern in pediatric hospitals and pediatric…”
    Get full text
    Journal Article
  14. 14

    Impact of ontogeny on linezolid disposition in neonates and infants by Kearns, Gregory L., Jungbluth, Gail L., Abdel‐Rahman, Susan M., Hopkins, Nancy K., Welshman, Ian R., Grzebyk, Rosie P., Bruss, Jon B., Anker, John N.

    Published in Clinical pharmacology and therapeutics (01-11-2003)
    “…The impact of age on linezolid disposition during the first few months of life has not been previously investigated. We characterized linezolid…”
    Get full text
    Journal Article
  15. 15

    Linezolid for the treatment of complicated skin and skin structure infections in children by YOGEV, RAM, PATTERSON, LORI E, KAPLAN, SHELDON L, ADLER, STUART, MORFIN, MARIA RAYO, MARTIN, AMANDO, EDGE-PADBURY, BARBARA, NABERHUIS-STEHOUWER, SHARON, BRUSS, JON B

    Published in The Pediatric infectious disease journal (01-09-2003)
    “…BACKGROUND.Gram-positive pathogens are a major cause of complicated skin and skin structure infections (CSSSIs) in children. Many pathogens are developing…”
    Get full text
    Journal Article
  16. 16

    A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid by Wilson, Samuel Eric, Solomkin, Joseph S, Le, Vu, Cammarata, Sue K, Bruss, Jon B

    Published in The American journal of surgery (01-04-2003)
    “…Severity scoring systems are useful for assessing patient risk and predicting prognosis. We developed a scoring system using data from a phase III study…”
    Get full text
    Journal Article